420 related articles for article (PubMed ID: 16094272)
1. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
2. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
4. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
6. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
7. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.
Matsumoto T; Toyoda H; Dohzono S; Yasuda H; Wakitani S; Nakamura H; Takaoka K
Eur Spine J; 2012 Jul; 21(7):1338-45. PubMed ID: 22203476
[TBL] [Abstract][Full Text] [Related]
9. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
10. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
11. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
12. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
13. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
14. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
[TBL] [Abstract][Full Text] [Related]
16. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
18. How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?
Cheng JC; Guo X; Law LP; Lee KM; Chow DH; Rosier R
Spine (Phila Pa 1976); 2002 Mar; 27(5):467-74. PubMed ID: 11880831
[TBL] [Abstract][Full Text] [Related]
19. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
20. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
